Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Norway (1)
Policy
Musculoskeletal/Multiple Sclerosis (MS) (1)
Government (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Roles and responsibilities
Clinical study phase I